Shenmiao Yang

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study

Wei Xu, Shenmiao Yang, Keshu Zhou et al. · Journal of Hematology & Oncology · 2020 · 129 citations · Full text

Medicine, Oncology, Pharmacology +15

Efficacy and safety of GLS-010 (zimberelimab) in patients with relapsed or refractory classical Hodgkin lymphoma: A multicenter, single-arm, phase II study

Ningjing Lin, Mingzhi Zhang, Hai Bai et al. · European Journal of Cancer · 2021 · 50 citations · Full text

Medicine, Oncology, Pharmacology +17

Ethnic and geographic diversity of chronic lymphocytic leukaemia

Shenmiao Yang, Abraham Varghese, Nitin Sood et al. · Leukemia · 2020 · 48 citations

Medicine, Hematology, Immunology +14

Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study

Wei Xu, Keshu Zhou, Tingyu Wang et al. · American Journal of Hematology · 2023 · 38 citations · Full text

Medicine, Oncology, Pharmacology +14

ADAM28 promotes tumor growth and dissemination of acute myeloid leukemia through IGFBP-3 degradation and IGF-I-induced cell proliferation

Jiamin Zhang, Chen‐Cong Wang, Gao‐Chao Zhang et al. · Cancer Letters · 2018 · 33 citations

Medicine, Molecular Biology, Oncology +10